How insulin switches on glycogen synthase
Glycogen synthase is kept inactive by phosphorylation. The kinase GSK3 is one of the enzymes that phosphorylates it. Insulin signaling through Akt inhibits GSK3, which allows protein phosphatase 1 to remove the inhibitory phosphates from glycogen synthase. The enzyme becomes active and adds glucose units to glycogen chains. The same logic applies in liver and in muscle, though the liver uses glycogen to buffer blood glucose for the whole body while muscle keeps it for its own contraction.
How insulin reduces hepatic glucose output
The liver releases glucose by breaking down glycogen and by making new glucose through gluconeogenesis. Insulin acts on both routes. It reduces transcription of the gluconeogenic enzymes PEPCK and G6Pase, so the liver builds less glucose from lactate, glycerol, and amino acids. It also lowers the flow of those substrates to the liver and favors storing them as glycogen or fat. Because the liver is the main source of blood glucose during fasting, this suppression is a major part of how insulin lowers blood glucose.
Two time scales of insulin action
Minutes
- GLUT4 vesicle translocation and increased glucose uptake
- Dephosphorylation and activation of glycogen synthase
- Inhibition of GSK3 through Akt
Hours
- Reduced transcription of PEPCK and G6Pase
- Lower gluconeogenic substrate supply
- Shift of glucose into glycogen and fat stores
Insulin lowers blood glucose through three coordinated outputs: more glucose enters muscle and adipose tissue through GLUT4, more of it is stored as glycogen, and less of it is released by the liver. The first two act within minutes; the suppression of hepatic glucose production develops over hours.